EFTA00059383.pdf

-1 of 2 - OFFInORD FD-302 (Rev. 5-8-10) FEDERAL BUREAU OF INVESTIGATION Date of entry 12/19/2019 On August 21, 2019 at approximately 0845 hours the undersigned, along with Special Agent of the Office of the Inspector General, Special Agent of the Federal Bureau of Investigation and Assistant United States Attorneys for the Southern District of New York and did interview Federal Bureau of Prisons Psychiatrist Doctor , date of birth , at the Southern District of NY. Dr. informed that she has been with the BOP since 07/17/2000 and that she has been the staff psychiatrist since 2002. Dr. advised as to the procedures and policies in place at the MCC for her role and how inmates meet with the psychiatrists. Dr. informed that she met with EPSTEIN on 07/23/2019 and conducted a suicide risk assessment. According to EPSTEIN had no clear recollection of the incident. EPSTEIN went on to even tell that he is "too much of a coward" to commit suicide, that he "doesn't like pain" and that suicide goes against his Jewish religion. Also according to , EPSTEIN had many normal interactions with those in the psych unit and even those guards that were assigned to observe him. did advise the staff that EPSTEIN would need a cellmate. When the psych staff reviewed EPSTEIN's file in their routine meetings EPSTEIN yielded no factors that would have placed him back in suicide watch. Dr. stated that had she or her department been notified that EPSTEIN changed his will that that would have been a factor that would have warranted a review of his mental state and would have probably been placed back in suicide watch. The interview concluded at 0930 hours. Further details of the interview and statements made by Dr. are recorded on the interview notes which are attached to this report. imcgigmionon 08/21/2019 at New York, New York, United States (In Person) Hle# 90A-NY-3151227 Datedmied 12/18/2019 by This document contains neither recommendations nor conclusions of the FBI. It is the property of the F131 and is loaned to your agency: it and its contents am not to be distributed outside your agency. EFTA00059383 FD-302a (Rev. 5-8-10) 90A-NY-3151227 Continuation ofFD-302 of (U) Interview of Dr. on 08/21/2019 i n s, 2 of 2 EFTA00059384